Recent studies already support this hypothesis, reporting hyperthermia to enhance apoptosis induced by TRAIL or the DR4-targeting mapatumumab in colon cancer cells in vitro and in vivo65,66. The gene discussed is TNFSF10; the disease is colonic neoplasm.